open access

Vol 50, No 3 (2018)
Special articles
Published online: 2018-08-17
Submitted: 2018-07-16
Accepted: 2018-07-21
Get Citation

Postoperative pain management — 2018 consensus statement of the Section of Regional Anaesthesia and Pain Therapy of the Polish Society of Anaesthesiology and Intensive Therapy, the Polish Society of Regional Anaesthesia and Pain Therapy, the Polish Association for the Study of Pain and the National Consultant in Anaesthesiology and Intensive Therapy

Hanna Misiołek, Renata Zajączkowska, Andrzej Daszkiewicz, Jarosław Woroń, Jan Dobrogowski, Jerzy Wordliczek, Radosław Owczuk
DOI: 10.5603/AIT.2018.0026
·
Pubmed: 30124229
·
Anaesthesiol Intensive Ther 2018;50(3):173-199.

open access

Vol 50, No 3 (2018)
Special articles
Published online: 2018-08-17
Submitted: 2018-07-16
Accepted: 2018-07-21

Abstract

brak

Abstract

brak

Get Citation

Keywords

brak

About this article
Title

Postoperative pain management — 2018 consensus statement of the Section of Regional Anaesthesia and Pain Therapy of the Polish Society of Anaesthesiology and Intensive Therapy, the Polish Society of Regional Anaesthesia and Pain Therapy, the Polish Association for the Study of Pain and the National Consultant in Anaesthesiology and Intensive Therapy

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 50, No 3 (2018)

Pages

173-199

Published online

2018-08-17

DOI

10.5603/AIT.2018.0026

Pubmed

30124229

Bibliographic record

Anaesthesiol Intensive Ther 2018;50(3):173-199.

Keywords

brak

Authors

Hanna Misiołek
Renata Zajączkowska
Andrzej Daszkiewicz
Jarosław Woroń
Jan Dobrogowski
Jerzy Wordliczek
Radosław Owczuk

References (247)
  1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008; 372(9633): 139–144.
  2. Gerbershagen HJ, Pogatzki-Zahn E, Aduckathil S, et al. Procedure-specific risk factor analysis for the development of severe postoperative pain. Anesthesiology. 2014; 120(5): 1237–1245.
  3. Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003; 97(2): 534–540.
  4. Gan TJ, Habib AS, Miller TE, et al. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014; 30(1): 149–160.
  5. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367(9522): 1618–1625.
  6. Pöpping DM, Elia N, Marret E, et al. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg. 2008; 143(10): 990–999; discussion 1000.
  7. Singh N, Sidawy AN, Dezee K, et al. The effects of the type of anesthesia on outcomes of lower extremity infrainguinal bypass. J Vasc Surg. 2006; 44(5): 964–968; discussion 968.
  8. Beattie WS, Badner NH, Choi PTL. Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia. Anesth Analg. 2003; 97(3): 919–920.
  9. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000; 321(7275): 1493.
  10. Kleiman AM, Sanders DT, Nemergut EC, et al. Chronic poststernotomy pain: incidence, risk factors, treatment, prevention, and the anesthesiologist's role. Reg Anesth Pain Med. 2017; 42(6): 698–708.
  11. Gerbershagen HJ, Aduckathil S, van Wijck AJ, et al. Pain intensity on the first day after surgery a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013; 118(4): 934–944.
  12. van Dijk JFM, van Wijck AJM, Kappen TH, et al. Postoperative pain assessment based on numeric ratings is not the same for patients and professionals: a cross-sectional study. Int J Nurs Stud. 2012; 49(1): 65–71.
  13. Schug SA, Palmer GM, Scott DA, et al. Acute pain management: scientific evidence, fourth edition, 2015. Med J Aust. 2016; 204(8): 315–317.
  14. Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain-from mechanisms to treatment. Pain Rep. 2017; 2(2): e588.
  15. Jaesche R, Gajewski P, Brożek J. Wytyczne praktyki klinicznej . In: Jaesche R, Gajewski P, Brożek J. ed. Podstawy EBM. Medycyna Praktyczna, Kraków 2008: 143–158.
  16. Plein LM, Rittner HL. Opioids and the immune system — friend or foe. Br J Pharmacol. 2018; 175(14): 2717–2725.
  17. Weber L, Yeomans DC, Tzabazis A. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies? Curr Opin Anaesthesiol. 2017; 30(4): 458–465.
  18. Tedore T. Regional anaesthesia and analgesia: relationship to cancer recurrence and survival. Br J Anaesth. 2015; 115 Suppl 2: ii34–ii45.
  19. Dobrogowski J, Zajączkowska R, Woroń J. Opioidowe leki przeciwbólowe. In: Wordliczek J, Dobrogowski J. ed. Leczenie bólu. PZWL, Warszawa 2017: 54–83.
  20. Chou R, Gordon D, Leon-Casasola Ode, et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. The Journal of Pain. 2016; 17(2): 131–157.
  21. Dobrogowski J, Wordliczek J, Woroń J. Farmakoterapia bólu. Termedia, Poznań 2014.
  22. Malec-Milewska M, Woroń J. Kompendium leczenia bólu. Medical Education, Warszawa 2017.
  23. Kaye A. Pharmacology. Anesthesiology Clinics. 2017; 35(2).
  24. Gupta A, Bah M. NSAIDs in the Treatment of Postoperative Pain. Curr Pain Headache Rep. 2016; 20(11): 62.
  25. Young RJ, Nguyen M, Nelson E. Pain medicine: an essential review. Springer, Switzerland 2017.
  26. Schroer WC, Diesfeld PJ, LeMarr AR, et al. Modifiable risk factors in primary joint arthroplasty increase 90-day cost of care. J Arthroplasty. 2018 [Epub ahead of print].
  27. Scott MJ, McEvoy MD, Gordon DB, et al. Perioperative Quality Initiative (POQI) I Workgroup, Perioperative Quality Initiative (POQI) I Workgroup, Perioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) Joint Consensus Statement on optimal analgesia within an enhanced recovery pathway for colorectal surgery: part 2-from PACU to the transition home. Perioper Med (Lond). 2017; 6: 7.
  28. Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 2008; 18(10): 915–921.
  29. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2006; 79(1): 9–19.
  30. Ayoub SS, Colville-Nash PR, Willoughby DA, et al. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol. 2006; 538(1-3): 57–65.
  31. Bertolini A, Ferrari A, Ottani A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006; 12(3-4): 250–275.
  32. Hinz B, Brune K. Cyclooxygenase-2--10 years later. J Pharmacol Exp Ther. 2002; 300(2): 367–375.
  33. Howard SS. Potential Analgesic Mechanisms of Acetaminophen. Pain Physician. 2009; 12: 269–280.
  34. Jasiecka A, Maślanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014; 17(1): 207–214.
  35. Nascimento J, Souza JR, Bonfante E, et al. Evaluation of the hematological alterations after the therapeutic use of dipyrone sodium in healthly volunteers. Basic and Clin Pharmacol Toxicol. 2014; 115(70 Suppl. 1).
  36. Oreskovic Z, Bicanic G, Hrabac P, et al. Treatment of postoperative pain after total hip arthroplasty: comparison between metamizol and paracetamol as adjunctive to opioid analgesics-prospective, double-blind, randomised study. Arch Orthop Trauma Surg. 2014; 134(5): 631–636.
  37. Lampl C, Likar R. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis]. Schmerz. 2014; 28(6): 584–590.
  38. Ramiro MG, Guardo LA, Álvarez AM, et al. Eficacia de la asociación paracetamol-metamizol vs. paracetamol-dexketoprofeno en manejo de dolor agudo postoperatorio. Revista de la Sociedad Española del Dolor. 2013; 20(6): 279–284.
  39. Theiler R, Dudler J. Drug therapy of pain. Revue Medicale Suisse. 2013; 401: 1846–1853.
  40. Sugumar R, Krishnaiah V, Channaveera GS, et al. Comparison of the pattern, efficacy, and tolerability of self-medicated drugs in primary dysmenorrhea: a questionnaire based survey. Indian J Pharmacol. 2013; 45(2): 180–183.
  41. Howell T, Bachmaier N, Lange A, et al. Metamizol in postoperative neonatal intensive care. Intensive Care Medicine. 2013; 39(suppl. 1): S137–S138.
  42. Vera P, Zapata L, Gich I, et al. [Hemodynamic and antipyretic effects of paracetamol, metamizol and dexketoprofen in critical patients]. Med Intensiva. 2012; 36(9): 619–625.
  43. Aganovic D, Prcic A, Kulovac B, et al. Clinical decision making in renal pain management. Acta Inform Med. 2012; 20(1): 18–21.
  44. Pogatzki-Zahn EM, Schnabel A, Zahn PK. Room for improvement: unmet needs in postoperative pain management. Expert Rev Neurother. 2012; 12(5): 587–600.
  45. Chaparro LE, Lezcano W, Alvarez HD, et al. Analgesic effectivess of Dipyrone for postoperative pain after herniorrhaphy. Pain Practice. 2012; 12(2): 142–147.
  46. Varga Z, Kriska M, Kristova V. Prescription of NSAIDs and risk of cardiovascular adverse effects in hospitalized patients. Rheumatologia. 2010; 24(3): 87–90.
  47. Houweling PL, Molag ML, van Boekel RLM, et al. Postoperative pain treatment' practice guideline revised. Ned Tijdschr Geneeskd. 2013; 157(49): A7005.
  48. Marret E, Rolin M, Beaussier M, et al. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008; 95(11): 1331–1338.
  49. McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010; 70(9): 1149–1163.
  50. Vigneault L, Turgeon AF, Côté D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011; 58(1): 22–37.
  51. Sun Y, Li T, Wang N, et al. Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2012; 55(11): 1183–1194.
  52. Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015(7): CD009642.
  53. Barreveld A, Witte J, Chahal H, et al. Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesth Analg. 2013; 116(5): 1141–1161.
  54. Dunn LK, Durieux ME. Perioperative use of intravenous lidocaine. Anesthesiology. 2017; 126(4): 729–737.
  55. Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015(7): CD009642.
  56. Lussier D, Beaulieu P. Toward a rational taxonomy of analgesic drugs. In: Beaulieu P, Beaulieu P. ed. Pharmacology of pain. IASP Press, Seattle 2010: 37.
  57. Eipe N, Gupta S, Penning J. Intravenous lidocaine for acute pain: an evidence-based clinical update. BJA Education. 2016; 16(9): 292–298.
  58. Eipe N, Gupta S, Penning J. Intravenous lidocaine for acute pain: an evidence-based clinical update. BJA Education. 2016; 16(9): 292–298.
  59. Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015(7): CD009642.
  60. Koppert W, Weigand M, Neumann F, et al. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004; 98(4): 1050–5, table of contents.
  61. Araujo MC, Sinnott CJ, Strichartz GR. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions. Pain. 2003; 103(1-2): 21–29.
  62. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology. 1994; 80(2): 383–91; discussion 25A.
  63. Rowlingson JC, DiFazio CA, Foster J, et al. Lidocaine as an analgesic for experimental pain. Anesthesiology. 1980; 52(1): 20–22.
  64. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth. 1982; 54(5): 501–505.
  65. Dirks J, Fabricius P, Petersen KL, et al. The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg. 2000; 91(4): 967–972.
  66. Attal N, Rouaud J, Brasseur L, et al. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology. 2004; 62(2): 218–225.
  67. Wallace MS, Laitin S, Licht D, et al. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology. 1997; 86(6): 1262–1272.
  68. Schmidt R, Schmelz M, Forster C, et al. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci. 1995; 15(1 Pt 1): 333–341.
  69. Weidner C, Schmelz M, Schmidt R, et al. Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci. 1999; 19(22): 10184–10190.
  70. Koppert W, Zeck S, Sittl R, et al. Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans. Anesthesiology. 1998; 89(6): 1345–1353.
  71. Weidner C, Schmelz M, Schmidt R, et al. Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci. 1999; 19(22): 10184–10190.
  72. Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000; 85(1-2): 217–224.
  73. Koppert W, Weigand M, Neumann F, et al. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004; 98(4): 1050–5, table of contents.
  74. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain. 1985; 23(4): 361–374.
  75. Bach FW, Jensen TS, Kastrup J, et al. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain. 1990; 40(1): 29–34.
  76. Koppert W, Ostermeier N, Sittl R, et al. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain. 2000; 85(1-2): 217–224.
  77. Lauretti GR. Mechanisms of analgesia of intravenous lidocaine. Rev Bras Anestesiol. 2008; 58(3): 280–286.
  78. de Oliveira CM, Issy AM, Sakata RK. Intraoperative intravenous lidocaine. Rev Bras Anestesiol. 2010; 60(3): 325–333.
  79. Couceiro T, Lima L, Couceiro L, et al. Intravenous lidocaine to treat postoperative pain. Revista Dor. 2014; 15(1).
  80. Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000; 93(3): 858–875.
  81. Dunn LK, Durieux ME. Perioperative use of intravenous lidocaine. Anesthesiology. 2017; 126(4): 729–737.
  82. Gonda X. Basic pharmacology of NMDA receptors. Curr Pharm Des. 2012; 18(12): 1558–1567.
  83. Hocking G, Visser EJ, Schug SA. Ketamine: does life begin at 40? Pain: Clinical Updates (IASP). 2007; 15: 1–6.
  84. Petrenko AB, Yamakura T, Sakimura K, et al. Defining the role of NMDA receptors in anesthesia: are we there yet? Eur J Pharmacol. 2014; 723: 29–37.
  85. Aryana P, Rajaei S, Bagheri A, et al. Acute effect of intravenous administration of magnesium sulfate on serum levels of interleukin-6 and tumor necrosis factor-α in patients undergoing elective coronary bypass graft with cardiopulmonary bypass. Anesth Pain Med. 2014; 4(3): e16316.
  86. Murphy JD, Paskaradevan J, Eisler LL, et al. Analgesic efficacy of continuous intravenous magnesium infusion as an adjuvant to morphine for postoperative analgesia: a systematic review and meta-analysis. Middle East J Anaesthesiol. 2013; 22(1): 11–20.
  87. De Oliveira GS, Castro-Alves LJ, Khan JH, et al. Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2013; 119(1): 178–190.
  88. Albrecht E, Kirkham KR, Liu SS, et al. Peri-operative intravenous administration of magnesium sulphate and postoperative pain: a meta-analysis. Anaesthesia. 2013; 68(1): 79–90.
  89. Guo BL, Lin Y, Hu W, et al. Effects of Systemic Magnesium on Post-operative Analgesia: Is the Current Evidence Strong Enough? Pain Physician. 2015; 18(5): 405–418.
  90. Arumugam S, Lau CSM, Chamberlain R. Perioperative adjunct magnesium decreases postoperative opioid requirements — a meta-analysis. International Journal of Clinical Medicine. 2016; 07(05): 297–308.
  91. Hwang JY, Na HS, Jeon YT, et al. I.V. infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia. Br J Anaesth. 2010; 104(1): 89–93.
  92. Kumar M, Dayal N, Rautela RS, et al. Effect of intravenous magnesium sulphate on postoperative pain following spinal anesthesia. A randomized double blind controlled study. Middle East J Anaesthesiol. 2013; 22(3): 251–256.
  93. Kahraman F, Eroglu A. The effect of intravenous magnesium sulfate infusion on sensory spinal block and postoperative pain score in abdominal hysterectomy. Biomed Res Int. 2014; 2014: 236024.
  94. Blaudszun G, Lysakowski C, Elia N, et al. Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012; 116(6): 1312–1322.
  95. Bernard JM, Hommeril JL, Passuti N, et al. Postoperative analgesia by intravenous clonidine. Anesthesiology. 1991; 75(4): 577–582.
  96. De Kock MF, Pichon G, Scholtes JL. Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia. Can J Anaesth. 1992; 39(6): 537–544.
  97. Marinangeli F, Ciccozzi A, Donatelli F, et al. Clonidine for treatment of postoperative pain: a dose-finding study. Eur J Pain. 2002; 6(1): 35–42.
  98. Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997; 52(8): 736–744.
  99. Gurbet A, Basagan-Mogol E, Turker G, et al. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006; 53(7): 646–652.
  100. Ozkose Z, Demir FS, Pampal K, et al. Hemodynamic and anesthetic advantages of dexmedetomidine, an alpha 2-agonist, for surgery in prone position. Tohoku J Exp Med. 2006; 210(2): 153–160.
  101. Altindis NT, Karaaslan D, Peker TT, et al. Comparison of meperidine alone with meperidine plus dexmedetomidine for postoperative patient-controlled analgesia. Neurosciences (Riyadh). 2008; 13(2): 117–121.
  102. Alles SRA, Smith PA. The anti-allodynic gabapentinoids: myths, paradoxes, and acute effects. Neuroscientist. 2016 [Epub ahead of print].
  103. Tiippana EM, Hamunen K, Kontinen VK, et al. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007; 104(6): 1545–56, table of contents.
  104. Doleman B, Heinink TP, Read DJ, et al. A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain. Anaesthesia. 2015; 70(10): 1186–1204.
  105. Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: a meta-analysis. Br J Anaesth. 2011; 106(4): 454–462.
  106. Eipe N, Penning J, Yazdi F, et al. Perioperative use of pregabalin for acute pain — a systematic review and meta-analysis. Pain. 2015; 156(7): 1284–1300.
  107. Romundstad L, Stubhaug A. Glucocorticoids for acute and persistent postoperative neuropathic pain: what is the evidence? Anesthesiology. 2007; 107(3): 371–373.
  108. Gilron I. Corticosteroids in postoperative pain management: future research directions for a multifaceted therapy. Acta Anaesthesiol Scand. 2004; 48(10): 1221–1222.
  109. Strehl C, Buttgereit F. Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol. 2013; 380(1-2): 32–40.
  110. Coronel MF, Labombarda F, González SL. Neuroactive steroids, nociception and neuropathic pain: a flashback to go forward. Steroids. 2016; 110: 77–87.
  111. Skjelbred P, Løkken P. Post-operative pain and inflammatory reaction reduced by injection of a corticosteroid. A controlled trial in bilateral oral surgery. Eur J Clin Pharmacol. 1982; 21(5): 391–396.
  112. Skjelbred P, Løkken P. Reduction of pain and swelling by a corticosteroid injected 3 hours after surgery. Eur J Clin Pharmacol. 1982; 23(2): 141–146.
  113. Afman CE, Welge JA, Steward DL. Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials. Otolaryngol Head Neck Surg. 2006; 134(2): 181–186.
  114. Waldron NH, Jones CA, Gan TJ, et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth. 2013; 110(2): 191–200.
  115. Oliveira GDe, Almeida M, Benzon H, et al. Perioperative single dose systemic dexamethasone for postoperative pain. Anesthesiology. 2011; 115(3): 575–588.
  116. Li D, Wang C, Yang Z, et al. Effect of intravenous corticosteroids on pain management and early rehabilitation in patients undergoing total knee or hip arthroplasty: a meta-analysis of randomized controlled trials. Pain Pract. 2018; 18(4): 487–499.
  117. Dan AEB, Thygesen TH, Pinholt EM. Corticosteroid administration in oral and orthognathic surgery: a systematic review of the literature and meta-analysis. J Oral Maxillofac Surg. 2010; 68(9): 2207–2220.
  118. Diakos EA, Gallos ID, El-Shunnar S, et al. Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials. Clin Otolaryngol. 2011; 36(6): 531–542.
  119. Chen CC, Siddiqui FJ, Chen TL, et al. Dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing thyroidectomy: meta-analysis of randomized controlled trials. World J Surg. 2012; 36(1): 61–68.
  120. Lunn TH, Kehlet H. Perioperative glucocorticoids in hip and knee surgery — benefit vs. harm? A review of randomized clinical trials. Acta Anaesthesiol Scand. 2013; 57(7): 823–834.
  121. Yue C, Wei R, Liu Y. Perioperative systemic steroid for rapid recovery in total knee and hip arthroplasty: a systematic review and meta-analysis of randomized trials. J Orthop Surg Res. 2017; 12(1): 100.
  122. Tedore T. Regional anaesthesia and analgesia: relationship to cancer recurrence and survival. Br J Anaesth. 2015; 115 Suppl 2: ii34–ii45.
  123. Plein LM, Rittner HL. Opioids and the immune system — friend or foe. Br J Pharmacol. 2018; 175(14): 2717–2725.
  124. Weber L, Yeomans DC, Tzabazis A. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies? Curr Opin Anaesthesiol. 2017; 30(4): 458–465.
  125. Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011; 14: 145–161.
  126. Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014; 112(5): 906–911.
  127. Steyaert A, Forget P, Dubois V, et al. Does the perioperative analgesic/anesthetic regimen influence the prevalence of long-term chronic pain after mastectomy? J Clin Anesth. 2016; 33: 20–25.
  128. Cata JP, Bugada D, De Andrés J. Opioid less perioperative care. Minerva Anestesiol. 2017; 83(3): 315–320.
  129. Chaparro LE, Smith SA, Moore RA, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. 2013(7): CD008307.
  130. Chapman CR, Vierck CJ. The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms. J Pain. 2017; 18(4): 359.e1–359.e38.
  131. Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016; 32(2): 160–167.
  132. Iacobucci GJ, Visnjevac O, Pourafkari L, et al. Ketamine: an update on cellular and subcellular mechanisms with implications for clinical practice. Pain Physician. 2017; 20(2): E285–E301.
  133. Parashchanka A, Schelfout S, Coppens M. Role of novel drugs in sedation outside the operating room: dexmedetomidine, ketamine and remifentanil. Curr Opin Anaesthesiol. 2014; 27(4): 442–447.
  134. Ali HM, Mokhtar AM. Effect of single compared to repeated doses of intravenous S(+) ketamine on the release of pro-inflammatory cytokines in patients undergoing radical prostatectomy. Anesth Essays Res. 2017; 11(2): 282–286.
  135. Macintyre PE. Acute pain management. Scientific Evidence ANZCA 2015.
  136. Vadivelu N, Schermer E, Kodumudi V, et al. Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016; 32(3): 298–306.
  137. Haile CN, Murrough JW, Iosifescu DV, et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014; 17(2): 331–336.
  138. Kelmendi B, Adams TG, Yarnell S, et al. PTSD: from neurobiology to pharmacological treatments. Eur J Psychotraumatol. 2016; 7: 31858.
  139. Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016; 32(2): 160–167.
  140. Pourmand A, Mazer-Amirshahi M, Royall C, et al. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017; 35(6): 918–921.
  141. Petz L, Tyner S, Barnard Ed, et al. Prehospital and en route analgesic use in the combat setting: a prospectively designed, multicenter, observational study. Military Medicine. 2015; 180(3S): 14–18.
  142. Lee EN, Lee JH. The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis. PLoS One. 2016; 11(10): e0165461.
  143. Ghate G, Clark E, Vaillancourt C. Systematic review of the use of low-dose ketamine for analgesia in the emergency department. CJEM. 2018; 20(1): 36–45.
  144. Johansson J, Sjöberg J, Nordgren M, et al. Prehospital analgesia using nasal administration of S-ketamine — a case series. Scand J Trauma Resusc Emerg Med. 2013; 21: 38.
  145. Yeaman F, Meek R, Egerton-Warburton D, et al. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients. Emerg Med Australas. 2014; 26(3): 237–242.
  146. Ferguson I, Bell A, Treston G, et al. Propofol or ketofol for procedural sedation and analgesia in emergency medicine — the POKER study: a randomized double-blind clinical trial. Ann Emerg Med. 2016; 68(5): 574–582.e1.
  147. Parashchanka A, Schelfout S, Coppens M. Role of novel drugs in sedation outside the operating room: dexmedetomidine, ketamine and remifentanil. Curr Opin Anaesthesiol. 2014; 27(4): 442–447.
  148. Jalili M, Bahreini M, Doosti-Irani A, et al. Ketamine-propofol combination (ketofol) vs propofol for procedural sedation and analgesia: systematic review and meta-analysis. Am J Emerg Med. 2016; 34(3): 558–569.
  149. Stevens AJ, Higgins MD. A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain. Acta Anaesthesiol Scand. 2017; 61(3): 268–280.
  150. Levin DN, Dulberg Z, Chan AW, et al. A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery. Can J Anaesth. 2017; 64(4): 385–395.
  151. Beaulieu P, Boulanger A, Desroches J, et al. Medical cannabis: considerations for the anesthesiologist and pain physician. Can J Anaesth. 2016; 63(5): 608–624.
  152. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015; 313(24): 2456–2473.
  153. Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012; 13(5): 438–449.
  154. Maida V, Daeninck PJ. A user's guide to cannabinoid therapies in oncology. Curr Oncol. 2016; 23(6): 398–406.
  155. Schrot RJ, Hubbard JR. Cannabinoids: medical implications. Ann Med. 2016; 48(3): 128–141.
  156. Dobrogowski J, Woroń J. Miejsce kannabinoidów w leczeniu bólu, kompendium leczenia bólu. Medical Education 2017: 139–148.
  157. Committee on Advancing Pain Research, Care, and Education: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC, Institute of Medicine of the National Academies, 2011.
  158. Hibbard JH. Engaging health care consumers to improve the quality of care. Med Care. 2003; 41(1 Suppl): I61–I70.
  159. Patanwala AE, Jarzyna DL, Miller MD, et al. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty. Pharmacotherapy. 2008; 28(12): 1453–1460.
  160. Chou R, Thames LL, Dana T, Pappas M, Mitchell JP. Evidence review on the management of postoperative pain. American Pain Society, Glenview 2016.
  161. Beyer JE, Villarruel AM, Deynes MJ. The oucher: user’s manual and technical report. http://www.oucher.org/downloads/2009_Users_Manual.pdf (8.01.2016).
  162. Prowse M. Postoperative pain in older people: a review of the literature. J Clin Nurs. 2007; 16(1): 84–97.
  163. Herr KA, Spratt K, Mobily PR, et al. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004; 20(4): 207–219.
  164. Morrison RS, Ahronheim JC, Morrison GR, et al. Pain and discomfort associated with common hospital procedures and experiences. J Pain Symptom Manage. 1998; 15(2): 91–101.
  165. Gagliese L, Weizblit N, Ellis W, et al. The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients. Pain. 2005; 117(3): 412–420.
  166. Bergh I, Sjöström B, Odén A, et al. Assessing pain and pain relief in geriatric patients with non-pathological fractures with different rating scales. Aging (Milano). 2001; 13(5): 355–361.
  167. Gordon DB, de Leon-Casaola OA. Research gaps in practice for acute postperative pain management in adults: findings from a review of the evidence for an American Society Clinical Practice guideline. The Clinical Journal of Pain. 2016; 17(2): 158–166.
  168. Jöhr M, Chauvin M, Kehlet H, et al. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth Analg. 1993; 77(5): 1048–1056.
  169. Alam A, Gomes T, Zheng H, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012; 172(5): 425–430.
  170. Elia N, Lysakowski C, Tramèr MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005; 103(6): 1296–1304.
  171. Maund E, McDaid C, Rice S, et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review. Health Technol Assess. 2010; 14(17): 1–153, iii.
  172. Rawal N, Viscusi E, Buvanendran A, et al. Multimodal minus reuben. Anesthesiol News. 2009; 35.
  173. Shafer S. Retraction notice. Anesthesia & Analgesia. 2009; 108(4): 1351.
  174. Rawal N. Current issues in postoperactive pain management. Eur J Anaesthesiol. 2016; 33: 160–171.
  175. Mathiesen O, Wetterslev J, Kontinen VK, et al. Scandinavian Postoperative Pain Alliance (ScaPAlli). Adverse effects of perioperative paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand. 2014; 58(10): 1182–1198.
  176. Dahl JB, Nielsen RV, Wetterslev J, et al. Scandinavian Postoperative Pain Alliance (ScaPAlli). Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand. 2014; 58(10): 1165–1181.
  177. Ruetzler K, Blome CJ, Nabecker S, et al. A randomised trial of oral versus intravenous opioids for treatment of pain after cardiac surgery. J Anesth. 2014; 28(4): 580–586.
  178. Ong CKS, Lirk P, Seymour RA, et al. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005; 100(3): 757–73, table of contents.
  179. U.S. Food and Drug Administration: Extended Release - Long Acting Opioid Analgesics. http://www. fda.gov/Safety/MedWatch/SafetyInformation/ucm396503. htm (9.12.2015).
  180. Tramèr MR, Williams JE, Carroll D, et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol Scand. 1998; 42(1): 71–79.
  181. Snell P, Hicks C. An exploratory study in the UK of the effectiveness of three different pain management regimens for post-caesarean section women. Midwifery. 2006; 22(3): 249–261.
  182. Saudan S, Habre W, Ceroni D, et al. Safety and efficacy of patient controlled epidural analgesia following pediatric spinal surgery. Paediatr Anaesth. 2008; 18(2): 132–139.
  183. Anghelescu DL, Faughnan LG, Oakes LL, et al. Parent-controlled PCA for pain management in pediatric oncology: is it safe? J Pediatr Hematol Oncol. 2012; 34(6): 416–420.
  184. Monitto CL, Greenberg RS, Kost-Byerly S, et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesth Analg. 2000; 91(3): 573–579.
  185. Russell AW, Owen H, Ilsley AH, et al. Background infusion with patient-controlled analgesia: effect on postoperative oxyhaemoglobin saturation and pain control. Anaesth Intensive Care. 1993; 21(2): 174–179.
  186. Guler T, Unlugenc H, Gundogan Z, et al. A background infusion of morphine enhances patient-controlled analgesia after cardiac surgery. Can J Anaesth. 2004; 51(7): 718–722.
  187. George JA, Lin EE, Hanna MN, et al. The effect of intravenous opioid patient-controlled analgesia with and without background infusion on respiratory depression: a meta-analysis. J Opioid Manag. 2010; 6(1): 47–54.
  188. Jarzyna D, Jungquist CR, Pasero C, et al. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression. Pain Manag Nurs. 2011; 12(3): 118–145.e10.
  189. Pedersen T, Dyrlund Pedersen B, Møller AM. Pulse oximetry for perioperative monitoring. Cochrane Database Syst Rev. 2003(3): CD002013.
  190. McCarter T, Shaik Z, Scarfo K, et al. Capnography monitoring enhances safety of postoperative patient-controlled analgesia. Am Health Drug Benefits. 2008; 1(5): 28–35.
  191. Liao Pu, Yegneswaran B, Vairavanathan S, et al. Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study. Can J Anaesth. 2009; 56(11): 819–828.
  192. Dodwell ER, Latorre JG, Parisini E, et al. NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif Tissue Int. 2010; 87(3): 193–202.
  193. Gorissen KJ, Benning D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. Br J Surg. 2012; 99(5): 721–727.
  194. Sucato DJ, Lovejoy JF, Agrawal S, et al. Postoperative ketorolac does not predispose to pseudoarthrosis following posterior spinal fusion and instrumentation for adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2008; 33(10): 1119–1124.
  195. Rutegård J, Rutegård M. Non-steroidal anti-inflammatory drugs in colorectal surgery: A risk factor for anastomotic complications? World J Gastrointest Surg. 2012; 4(12): 278–280.
  196. Healthcare Professionals: Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)*. http:// www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafety InformationforPatientsandProviders/DrugSafetyInformation forHeathcareProfessionals/ucm085282.htm (30.10.2014).
  197. Ekman EF, Wahba M, Ancona F. Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. Arthroscopy. 2006; 22(6): 635–642.
  198. Huang YM, Wang CM, Wang CT, et al. Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. BMC Musculoskelet Disord. 2008; 9: 77.
  199. Sun T, Sacan O, White PF, et al. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesth Analg. 2008; 106(3): 950–8, table of contents.
  200. Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: a meta-analysis. Br J Anaesth. 2011; 106(4): 454–462.
  201. Straube S, Derry S, Moore RA, et al. Single dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database Syst Rev. 2010(5): CD008183.
  202. Gonano C, Latzke D, Sabeti-Aschraf M, et al. The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery. J Psychopharmacol. 2011; 25(2): 249–253.
  203. Bell RF, Dahl JB, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2006(1): CD004603.
  204. Laskowski K, Stirling A, McKay WP, et al. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011; 58(10): 911–923.
  205. McNicol ED, Schumann R, Haroutounian S. A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain. Acta Anaesthesiol Scand. 2014; 58(10): 1199–1213.
  206. Loftus RW, Yeager MP, Clark JA, et al. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010; 113(3): 639–646.
  207. Marret E, Rolin M, Beaussier M, et al. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008; 95(11): 1331–1338.
  208. Vigneault L, Turgeon AF, Côté D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011; 58(1): 22–37.
  209. De Oliveira GS, Duncan K, Fitzgerald P, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014; 24(2): 212–218.
  210. Farag E, Ghobrial M, Sessler DI, et al. Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology. 2013; 119(4): 932–940.
  211. Bamigboye AA, Hofmeyr GJ. Local anaesthetic wound infiltration and abdominal nerves block during caesarean section for postoperative pain relief. Cochrane Database Syst Rev. 2009(3): CD006954.
  212. Kehlet H, Andersen LØ. Local infiltration analgesia in joint replacement: the evidence and recommendations for clinical practice. Acta Anaesthesiol Scand. 2011; 55(7): 778–784.
  213. Parker RD, Streem K, Schmitz L, et al. Marguerite Group. Efficacy of continuous intra-articular bupivacaine infusion for postoperative analgesia after anterior cruciate ligament reconstruction: a double-blinded, placebo-controlled, prospective, and randomized study. Am J Sports Med. 2007; 35(4): 531–536.
  214. Dasta J, Ramamoorthy S, Patou G, et al. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012; 28(10): 1609–1615.
  215. Rapley JH, Beavis RC, Barber FA. Glenohumeral chondrolysis after shoulder arthroscopy associated with continuous bupivacaine infusion. Arthroscopy. 2009; 25(12): 1367–1373.
  216. Joshi GP, Bonnet F, Shah R, et al. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg. 2008; 107(3): 1026–1040.
  217. Kaloul I, Guay J, Côté C, et al. The posterior lumbar plexus (psoas compartment) block and the three-in-one femoral nerve block provide similar postoperative analgesia after total knee replacement. Can J Anaesth. 2004; 51(1): 45–51.
  218. Richman JM, Liu SS, Courpas G, et al. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg. 2006; 102(1): 248–257.
  219. YaDeau JT, LaSala VR, Paroli L, et al. Clonidine and analgesic duration after popliteal fossa nerve blockade: randomized, double-blind, placebo-controlled study. Anesth Analg. 2008; 106(6): 1916–1920.
  220. Bamigboye AA, Hofmeyr GJ. Local anaesthetic wound infiltration and abdominal nerves block during caesarean section for postoperative pain relief. Cochrane Database Syst Rev. 2009(3): CD006954.
  221. Paul J, Arya A, Hurlburt L, et al. Femoral nerve block improves analgesia outcomes after total knee arthroplasty. Anesthesiology. 2010; 113(5): 1144–1162.
  222. Nishimori M, Low JHS, Zheng H, et al. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2006(3): CD005059.
  223. Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013; 111(5): 711–720.
  224. Huxtable CA, Roberts LJ, Somogyi AA, et al. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care. 2011; 39(5): 804–823.
  225. Reynolds MA. Postoperative pain management discharge teaching in a rural population. Pain Manag Nurs. 2009; 10(2): 76–84.
  226. Houle TT, Miller S, Lang JE, et al. Day-to-day experience in resolution of pain after surgery. Pain. 2017; 158(11): 2147–2154.
  227. Papagiannopoulou P, Argiriadou H, Georgiou M, et al. Surgical endoscopy. www.postoppain.org. 2003; 17(12): 1961–1964.
  228. Taliercio S, Sanders B, Achlatis S, et al. Factors Associated With the Use of Postoperative Analgesics in Patients Undergoing Direct Microlaryngoscopy. Ann Otol Rhinol Laryngol. 2017; 126(5): 375–381.
  229. Tolska HK, Takala A, Blomgren K, et al. Topical Ropivacaine in Prevention of Post-Tonsillectomy Pain in Adults. Anesth Analg. 2017; 124(5): 1459–1466.
  230. Aveline C, Le Hetet H, Le Roux A, et al. A survey of the administration of prednisolone versus ibuprofen analgesic protocols after ambulatory tonsillectomy. Anaesth Crit Care Pain Med. 2015; 34(5): 281–287.
  231. Arikan OK, Sahin S, Kazkayasi M, et al. High-dose ropivacaine versus bupivacaine for posttonsillectomy pain relief in adults. J Otolaryngol Head & Neck Surg. 2008; 37(6): 836–884.
  232. Wilson CA, Sommerfield D, Drake-Brockman TFE, et al. Pain after discharge following head and neck surgery in children. Paediatr Anaesth. 2016; 26(10): 992–1001.
  233. Bamigboye AA, Hofmeyr GJ, Cederholm I. Preliminary risk-benefit analysis of ropivacaine in labour and following surgery. Drug Saf. 1997; 16(6): 391–402.
  234. Blanco R. QLB vs TAP block. Reg Anesth Pain Med. 2016; 41(6): 757–762.
  235. Abdallah F, Chan V, Brull R. Transversus abdominis plane block. Regional Anesthesia and Pain Medicine. 2012; 37(2): 193–209.
  236. Abdallah FW, Laffey JG, Halpern SH, et al. Duration of analgesic effectiveness after the posterior and lateral transversus abdominis plane block techniques for transverse lower abdominal incisions: a meta-analysis. Br J Anaesth. 2013; 111(5): 721–735.
  237. Blanco R, Maldonado TP. Reply to the article entitled “Ultrasound description of Pecs II (modified Pecs I): A novel approach to breast surgery”. Reply of the authors. Revista Española de Anestesiología y Reanimación. 2013; 60(5): 296–297.
  238. Woodworth GE, Ivie RMJ, Nelson SM, et al. Perioperative breast analgesia: a qualitative review of anatomy and regional techniques. Reg Anesth Pain Med. 2017; 42(5): 609–631.
  239. Singh PM, Borle A, Kaur M, et al. Opioid-sparing effects of the thoracic interfascial plane blocks: A meta-analysis of randomized controlled trials. Saudi J Anaesth. 2018; 12(1): 103–111.
  240. Forero M, Adhikary SD, Lopez H, et al. The erector spinae plane block: a novel analgesic technique in thoracic neuropathic pain. Reg Anesth Pain Med. 2016; 41(5): 621–627.
  241. Yeung J J, Melody T, Kerr A, et al. Randomised controlled pilot study to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain: TOPIC feasibility study protocol. BMJ Open. 2016.
  242. Rodriguez-Aldrete D, Candiotti KA, Janakiraman R, et al. Trends and new evidence in the management of acute and chronic post-thoracotomy pain-an overview of the literature from 2005 to 2015. J Cardiothorac Vasc Anaesth. 2016; 30(3): 762–72.
  243. Scimia P, Basso Ricci E, Droghetti A, et al. The ultrasound-guided continuous erector spinae plane block for postoperative analgesia in video-aassisted thoracoscopic lobectomy. Reg Anesth Pain Med. 2017; 42(4): 537.
  244. Chin KiJ, McDonnell JG, Carvalho B, et al. Essentials of our current understanding: abdominal wall blocks. Reg Anesth Pain Med. 2017; 42(2): 133–183.
  245. Mudumbai SC, Kim TE, Howard SK, et al. Continuous adductor canal blocks are superior to continuous femoral nerve blocks in promoting early ambulation after TKA. Clin Orthop Relat Res. 2014; 472(5): 1377–1383.
  246. Shah NA, Jain NP. Is continuous adductor canal block better than continuous femoral nerve block after total knee arthroplasty? Effect on ambulation ability, early functional recovery and pain control: a randomized controlled trial. J Arthroplasty. 2014; 29(11): 2224–2229.
  247. Kopp SL, Børglum J, Buvanendran A, et al. Anesthesia and analgesia practice pathway options for total knee arthroplasty: an evidence-based review by the american and european societies of regional anesthesia and pain medicine. Reg Anesth Pain Med. 2017; 42(6): 683–697.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl